Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GenVec Value Slammed on Drug Failure
TheStreet.com
Tuesday, March 30, 2010 - 9:41am
tags:
GenVec, TNFerade, Medivation, Human Genome Sciences
FDA raises questions about Cephalon’s Nuvigil for jet lag disorder
Bizjournals.com
Tuesday, March 30, 2010 - 9:38am
tags:
Cephalon, NUVIGIL, jet lag, FDA
Cumberland applies for expanded use of liver drug
Yahoo/AP
Tuesday, March 30, 2010 - 9:35am
tags:
Cumberland, Acetadote
AstraZeneca, Abbott get FDA letter for Certriad
Marketwatch
Tuesday, March 30, 2010 - 9:34am
tags:
FDA, Abbott Laboratories, AstraZeneca, Certriad
Mirror, Mirror On The Wall… The Biggest Drugmakers
Pharmalot
Tuesday, March 30, 2010 - 9:27am
tags:
pharma industry
Astellas to Review OSI Pharma’s Books, May Face Rival Bidders
Bloomberg
Tuesday, March 30, 2010 - 9:25am
tags:
Astellas, OSI Pharmaceuticals, M&A
Abbott's White Is The (Only) One
CNBC
Tuesday, March 30, 2010 - 9:24am
tags:
Abbott Laboratories, Pharma CEOs, Miles White
Medivation lays off 20 percent of its staff
Yahoo/AP
Tuesday, March 30, 2010 - 9:22am
tags:
Medivation, layoffs
Pearl moves lung drug into Phase IIb trial
Bizjournals.com
Tuesday, March 30, 2010 - 9:21am
tags:
Pearl Therapeutics, COPD
Healthcare Reform Impact on Pharmaceutical Marketing
Pharmareform
Monday, March 29, 2010 - 12:08pm
tags:
healthcare reform, pharma marketing
Shire's Positive Data on Vpriv
Yahoo/Zacks.com
Monday, March 29, 2010 - 12:07pm
tags:
Shire, Vpriv, Gaucher disease
MDRNA's gains lead drug stocks; patents back in focus
Marketwatch
Monday, March 29, 2010 - 12:01pm
tags:
drug stocks, MDRNA, patents
A Sanofi Drug, A Web Site & Lack Of Disclosure
Pharmalot
Monday, March 29, 2010 - 11:59am
tags:
Multaq, Sanofi
Biotechs urged to feed Merck’s “much bigger beast”
Pharma Times, UK
Monday, March 29, 2010 - 11:56am
tags:
biotechs, Merck
GSK Offers Free Vaccines to Uninsured Adults
Yahoo
Monday, March 29, 2010 - 11:52am
tags:
vaccines, GSK
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Monday, March 29, 2010 - 11:23am
tags:
FDA, obesity, Vivus, Orexigen, Arena Pharmaceuticals, Qnexa, Amylin
FDA Likely to Deliver Blow to Cell Therapeutics
Seeking Alpha
Monday, March 29, 2010 - 11:19am
tags:
FDA, Cell Therapeutics, pixantrone
Arca BioPharma Patent Deja Vu
TheStreet.com
Monday, March 29, 2010 - 11:17am
tags:
ARCA biopharma, patents
Pfizer Shows Love for Targeted Therapeutics
Seeking Alpha
Monday, March 29, 2010 - 11:05am
tags:
Pfizer, Nodality, targeted therapeutics
Waiting period ends for Rigel-AstraZenenca deal
Yahoo/AP
Monday, March 29, 2010 - 10:54am
tags:
AstraZeneca, Rigel, licensing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.